Title:
USE OF ICARISID II OR PHARMACEUTICALLY ACCEPTABLE CARRIER THEREOF IN ERECTILE DYSFUNCTION
Document Type and Number:
WIPO Patent Application WO/2019/161719
Kind Code:
A1
Abstract:
Provided is the use of icarisid II or a pharmaceutically acceptable carrier thereof in erectile dysfunction. The use includes using icarisid II or the pharmaceutically acceptable carrier thereof for, specifically but not limited to, preventing and/or treating mammalian erectile dysfunction.
More Like This:
| JP2004505081 | Dihydronaphthalene potassium channel opener |
| JP5298129 | Soluble guanylate cyclase activator |
| WO/2001/022961 | NEW USE OF MODAFINIL AND THE D/L ENANTIOMER |
Inventors:
LIU JIEQING (CN)
XIN HUA (CN)
GU JINGLIANG (CN)
YAO ZHENG (CN)
XIN HUA (CN)
GU JINGLIANG (CN)
YAO ZHENG (CN)
Application Number:
PCT/CN2019/072160
Publication Date:
August 29, 2019
Filing Date:
January 17, 2019
Export Citation:
Assignee:
SUZHOU GUANGAO HEALTHCARE CO LTD (CN)
International Classes:
A61P15/10; A61K31/7048
Domestic Patent References:
| WO2009149621A1 | 2009-12-17 |
Foreign References:
| CN108392487A | 2018-08-14 | |||
| CN107964555A | 2018-04-27 | |||
| CN104711312A | 2015-06-17 |
Other References:
CHENG, TAO.: "Optimized Biotransformation of Icariin into Icariside II by beta-Glucosidase from Trichoderma viride Using Central Composite Design Method", BIOMED RESEARCH INTERNATIONAL, 31 December 2016 (2016-12-31), pages 1 - 10, XP055631712, ISSN: 2314-6141
Attorney, Agent or Firm:
SUZHOU FANGLVE PATENT AGENT FIRM ( ORDINARY (CN)
Download PDF:
Previous Patent: ATTRIBUTION METHOD AND APPARATUS
Next Patent: INFORMATION PUSHING METHOD AND RELATED PRODUCT
Next Patent: INFORMATION PUSHING METHOD AND RELATED PRODUCT